UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 28, 2022
Accession Number:
0001628280-22-007263
Submission Type:
POS AM
CIK:
0001811764
Company Name:
POINT Biopharma Global Inc.
File Number:
333-258325